Minocycline treatment results in reduced oral steroid requirements in adult asthma

Allergy and Asthma Proceedings

Volumn 29, Issue 3, 2008, Pages 286-294

  Daoud, Ammar ^a,b   Gloria, C J ^a   Taningco, Gladys ^a   Hammerschlag, Margaret R ^a   Weiss, Steven ^a   Gelling, Maureen ^a   Roblin, Patricia M ^a   Joks, Rauno ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Asthma; Chlamydia pneumoniae; Corticosteroid; Immunoglobulin e; Minocycline; Mycoplasma pneumoniae; Oral prednisone; Tetracycline

Indexed keywords

MINOCYCLINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ASTHMA; DRUG SYNERGISM; FEMALE; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPIROMETRY; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 46649085640     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3121     Document Type: Article

References (51)

1. Lemanske RF, and Busse WW. Asthma: Factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol 117:5456-5461, 2006.
2. Boushey HA. Experiences with monoclonal antibody therapy for allergic asthma. J Allergy Clin Immunol 108:577-583, 2001.
3. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 354:1589-1600, 2006.
4. O'Dell JR, Blakely KW, Mallek JA, et al. Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum 44:2235-2241, 2001.
5. Akamatsu H, Niwa Y, Kurokawa I, et al. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism. Arch Dermatol Res 283:524-528, 1991.
6. National Asthma Education and Prevention Program. Expert panel report 2: Guideline for the diagnosis and management of asthma. Publication No. 97-4051, National Institutes of Health, Bethesda, MD, April 1997.
7. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 148:727-732, 1994.
8. Emre U, Sokolovskaya N, Roblin PM, et al. Detection of antiChlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 172:265-267, 1995.
9. Hyman CL, Roblin PM, Gaydos CA, et al. The prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20:1174-1178, 1995.
10. Roblin PM, Dumornay W, and Hammerschlag MR. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 30:1968, 1992.
11. Foy H. Mycoplasma pneumonia. In Bacterial Infections of Humans: Epidemiology and Control, Evans AS, and Feldman HA. (eds.). 1st ed. New York: Plenum Medical Book Co., 357-360, 1982.
12. Ekstrom T, Osterman K, and Zetterstom O. Lack of effect of loratadine on moderate to severe asthma. Ann Allergy Asthma Immunol 75:287-289, 1995.
13. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials. Thorax 47:76-83, 1992.
14. Marin MG. Low dose methotrexate spares steroid usage in steroid-dependent asthmatic patients. Chest 112:29-33, 1997.
15. Bernstein IL, Bernstein DI, Dubb JW, et al. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. J Allergy Clin Immunol 98: 317-324, 1996.
16. Engelbrecht JA, Calhoon SL, and Scherrer JJ. Methotrexate pneumonitis after low-dose therapy for rheumatoid arthritis. Arthritis Rheum 26:1275, 1983.
17. Searles G, and McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: Potential risk factors. Four case reports and a review of the literature. J Rheumatol 16:186, 1987.
18. Schwimmer BP, and Parker KL. Adrenocorticotrophic hormone: Adrenocortical steroids and their synthetic analogs; inhibitor of the synthesis and action of adrenocortical hormones. In The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, Molinoff PB, et al. (Eds). New York: McGraw-Hill, 1459-1485, 1996.
19. Buckley LM, Leib ES, Cartularo KS, et al. Effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 22:1055-1099, 1995.
20. Harris ED Jr, Emkey RD, Nichols JE, et al. Low dose prednisone therapy in rheumatoid arthritis: A double blind study. J Rheum 10:713-721, 1983.
21. Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis: Relationship of computed tomographic findings to allergy, asthma, and eosinophils. JAMA 271:363-367, 1994.
22. Hahn DL, and McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol 81:339-344, 1998.
23. Hahn DL, Dodge RW, and Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266:225-230, 1991.
24. Gil JC, Cedillo RL, Mayagoita BG, et al. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 70:23-25, 1993.
25. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 158:998-1001, 1998. (Published Erratum appears in Am J Respir Crit Care Med 158:1692, 1998.)
26. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 107:595-601, 2001.
27. Apfalter P, Reischl U, and Hammerschlag MR. In-house nucleic acid amplification assays in research: How much quality control is needed before one can rely upon the results? J Clin Microbiol 43:5385-5841, 2005.
28. Kumar S, and Hammmerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: Current status of diagnostic methods. Clin Infect Dis 44:568-576, 2007.
29. Hammerschlag MR. Advances in the management of Chlamydia pneumoniae infections. Expert Rev Anti Infect Ther 1:493-504, 2003.
30. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-EIA, culture and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32:903-905, 1994.
31. MacCleod CM, Hamid QA, Tremblay C, et al. Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa. Adv Ther 18:75-82, 2001.
32. Richeldi L, Ferrara G, Fabbri LM, et al. Macrolides for chronic asthma (Review). The Cochrane Library (2)1-33, 2006. The Cochrane Collaboration. John Wiley & Sons, Ltd., Hoboken, NJ
33. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 177:148-155, 2008. (Epub Oct. 18, 2007).
34. Piacentini GL, Peroni DG, Bodini A, et al. Azithromycin reduces bronchial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children: A preliminary report. Allergy Asthma Proc 28:194-198, 2007.
35. Golub LM, Lee HM, and Ryan ME. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12:12-26, 1998.
36. Elewski BE, Lamb BAJ, Sams WM, and Gammon WR. In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol 8:807-812, 1983.
37. Van Barr HM, van de Kerkhof PC, Mier PD, et al. Tetracyclines are potent scavengers of the Superoxide radical. Br J Dermatol 117:131-132, 1987.
38. Forsgren A, Schmeling D, and Quie PG. Effect of tetracycline on the phagocytic function of human leucocytes. J Infect Dis 130:412-415, 1974.
39. Amin AR, Patel RN, Thakker GD, et al. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 410:259-264, 1997.
40. Hoyt JC, Ballering J, Numanami H, et al. Doxycycline modulates nitric oxide production in murine lung epithelial cells. J Immunol 176:567-572, 2006.
41. Shapira L, Soskolne WA, Houri Y, et al. Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: Correlation with inhibition of cytokine secretion. Infect Immun 64:825-828, 1996.
42. Milano S, Arcoleo F, D'Agostino P, et al. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother 41:117-121, 1997.
43. Ingham E, Turnbull L, and Kearney JN. The effects of minocycline and tetracycline on the mitotic response of human peripheral blood lymphocytes. J Antimicrob Chemother 27:607-617, 1991.
44. Smith-Norowitz TA, Bluth MH, Drew H, et al. Effect of minocycline and doxycyline on IgE responses. Ann Allergy Asthma Immunol 89:172-179, 2002.
45. Kuzin II, Snyder JE, Ugine GD, et al. Tetracycline inhibit activated B cell function. Intern Immunol 12:921-931, 2001.
46. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 343:269-280, 2000.
47. Joks R, Smith-Norowitz TA, Bluth MH, et al. Minocycline treatment of allergic asthmatic patients and BPO-KLH sensitized mice at the peak of the hapten specific IgE response suppresses IgE, but not IgM, IgG or IgA responses. J Allergy Clin Immunol 121:23, 2008.
48. Saivin S, and Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 15:355-366, 1988.
49. Naline E, Sanceaume M, Toty L, et al. Penetration of minocycline into lung tissues. Br J Clin Pharmacol 32:402-404, 1991.
50. Lee KS, Jin SM, Kim SS, et al. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 113:902-909, 2004.
51. Carney DE, McCann UG, Schiller HJ, et al. Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res 99:245-252, 2001.